biosig_rgb.png
BioSig Announces Reduction of its Workforce
February 20, 2024 10:00 ET | BioSig Technologies, Inc.
Westport, CT, Feb. 20, 2024 (GLOBE NEWSWIRE) -- -- BioSig Technologies, Inc. (NASDAQ: BSGM) ("BioSig" or the "Company"), a medical technology company, today announced that it has terminated a...
biosig_rgb.png
BioSig Announces Cost Reductions to Improve its Financial Standing and Shifts its Core Strategy
January 30, 2024 08:30 ET | BioSig Technologies, Inc.
Cost Savings Targeted to Reduce Cash Burn by 50% Core Strategy Shifts to Business Development and Distribution Partnerships Westport, CT, Jan. 30, 2024 (GLOBE NEWSWIRE) --  BioSig...
biosig_rgb.png
BioSig Issues Letter to Shareholders Detailing Technology Innovations and Strategic Focus for 2024
December 06, 2023 14:20 ET | BioSig Technologies, Inc.
Westport, CT, Dec. 06, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company delivering unprecedented accuracy and precision to...
biosig_rgb.png
BioSig Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
November 13, 2023 16:30 ET | BioSig Technologies, Inc.
Westport, CT, Nov. 13, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”) a medical technology company committed to delivering unprecedented accuracy and...
biosig_rgb.png
BioSig Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
November 09, 2023 08:00 ET | BioSig Technologies, Inc.
Westport, CT, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Westport, CT, Nov. 9, 2023 -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”) a medical technology company committed to...
biosig_rgb.png
BioSig Appoints Global MedTech Leader Fred Hrkac as New Executive VP
November 07, 2023 08:00 ET | BioSig Technologies, Inc.
Westport, CT, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Westport, CT, November 7, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company...
biosig_rgb.png
BioSig’s New PURE EP™ Subscription Model Adopted by Mayo Clinic-Phoenix for World-Class Cardiac Care
November 02, 2023 08:00 ET | BioSig Technologies, Inc.
Westport, CT, Nov. 02, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company committed to delivering unprecedented accuracy and...
biosig_rgb.png
BioSig's PURE EP™ Platform Debuts New Automated Features in First Patient Cases
August 22, 2023 08:00 ET | BioSig Technologies, Inc.
Westport, CT, Aug. 22, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company delivering unprecedented accuracy and precision to...
biosig_rgb.png
BioSig AI Sciences Receives $2.2 Million in Seed Funding to Advance Development of Artificial Intelligence Applications
July 25, 2023 08:30 ET | BioSig Technologies, Inc.
Westport, CT, July 25, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company delivering unprecedented accuracy and precision to...
biosig_rgb.png
BioSig AI Sciences Selected for NVIDIA Inception Partnership Program to Support R&D Collaboration on AI Medical Device Platform for Hospitals
July 20, 2023 07:11 ET | BioSig Technologies, Inc.
Westport, CT, July 20, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company delivering unprecedented accuracy and precision to...